GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin

Human Pathology

Volumn 45, Issue 8, 2014, Pages 1682-1687

  Bezerra, Stephania Martins ^a   Lotan, Tamara Levin ^a,b   Faraj, Sheila Friedrich ^a   Karram, Sarah ^a   Sharma, Rajni ^a   Schoenberg, Mark ^b   Bivalacqua, Trinity J ^b   Netto, George Jabboure ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Bladder; GATA3 immunohistochemistry; Lung; Prostate; Small cell carcinoma

Indexed keywords

TRANSCRIPTION FACTOR GATA 3;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER TISSUE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ETHNICITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIMARY TUMOR; PROSTATE ADENOCARCINOMA; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SARCOMATOID CARCINOMA; SENSITIVITY AND SPECIFICITY; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TRANSITIONAL CELL CARCINOMA; TUMOR INVASION; TUMOR LOCALIZATION; VERY ELDERLY;

BLADDER; GATA3 IMMUNOHISTOCHEMISTRY; LUNG; PROSTATE; SMALL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; FEMALE; GATA3 TRANSCRIPTION FACTOR; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84904601707     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.04.011     Document Type: Article

References (24)

1. S.P. Riaz, M. Luchtenborg, V.H. Coupland, J. Spicer, M.D. Peake, and H. Moller Trends in incidence of small cell lung cancer and all lung cancer Lung Cancer 75 2012 280 284
2. N. Rekhtman Neuroendocrine tumors of the lung: an update Arch Pathol Lab Med 134 2010 1628 1638
3. K. Haider, R.K. Shahid, and D. Finch et al. Extrapulmonary small cell cancer: a Canadian province's experience Cancer 107 2006 2262 2269
4. Y.N. Wong, R.H. Jack, V. Mak, M. Henrik, and E.A. Davies The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004 BMC Cancer 9 2009 209 215
5. J.N. Eble, G. Sauter, J.I. Epstein, and I.A. Sesterhenn World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs 2004 IARC Press Lyon
6. P.E. Clark, and P.E. Spiess National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Bladder Cancer. Version I.2014 Available at http://www.nccn.org/professionals/physician-gls/pdf/ bladder.pdf NCCN Guidelines 2013
7. A.O. Siefker-Radtke, C.P. Dinney, and N.A. Abrahams et al. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience J Urol 172 2004 481 484
8. S.M. Brennan, D.L. Gregory, A. Stillie, A. Herschtal, M. Mac Manus, and D.L. Ball Should extrapulmonary small cell cancer be managed like small cell lung cancer? Cancer 116 2010 888 895
9. J. Chou, S. Provot, and Z. Werb GATA3 in development and cancer differentiation: cells GATA have it! J Cell Physiol 222 2010 42 49
10. I.C. Ho, P. Vorhees, and N. Marin et al. Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene EMBO J 10 1991 1187 1192
11. L.J. Ko, M. Yamamoto, M.W. Leonard, K.M. George, P. Ting, and J.D. Engel Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer Mol Cell Biol 11 1991 2778 2784
12. R. Zheng, and G.A. Blobel GATA transcription factors and cancer Genes Cancer 1 2010 1178 1188
13. M.L. Asselin-Labat, K.D. Sutherland, and H. Barker et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation Nat Cell Biol 9 2007 201 209
14. H. Van Esch, P. Groenen, and M.A. Nesbit et al. GATA3 haplo-insufficiency causes human HDR syndrome Nature 406 2000 419 422
15. A. Cimino-Mathews, A.P. Subhawong, and P.B. Illei et al. GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas Hum Pathol 44 2013 1341 1349
16. A. Chang, A. Amin, and E. Gabrielson et al. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung Am J Surg Pathol 36 2012 1472 1476
17. W.D. Travis, E. Brambilla, H.K. Muller-Hermelink, and C.C. Harris World Health Organization Classification of Tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart 2004 IARC Press Lyon
18. H.L. Fedor, and A.M. De Marzo Practical methods for tissue microarray construction Methods Mol Med 103 2005 89 101
19. J.P. Higgins, G. Kaygusuz, and L. Wang et al. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray Am J Surg Pathol 31 2007 673 680
20. M. Miettinen, P.A. McCue, and M. Sarlomo-Rikala et al. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors Am J Surg Pathol 38 2014 13 22
21. A.M. Gruver, M.B. Amin, and D.J. Luthringer et al. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung Arch Pathol Lab Med 136 2012 1339 1346
22. T.L. Lotan, N.S. Gupta, and W. Wang et al. ERG gene rearrangements are common in prostatic small cell carcinomas Mod Pathol 24 2011 820 828
23. W. Wang, and J.I. Epstein Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases Am J Surg Pathol 32 2008 65 71
24. M.J. Fernandez-Acenero, S. Cordova, F. Manzarbeitia, and C. Medina Immunohistochemical profile of urothelial and small cell carcinomas of the bladder Pathol Oncol Res 17 2011 519 523